Preclinical and Clinical Efficacy of the Bisphosphonate Ibandronate in Cancer Treatment

E-ISSN： 2212-3938|3|1|1-10

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.3, Iss.1, 2008-01, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ibandronate in profile: drug characteristics and clinical efficacy

By Reginster Jean-Yves Neuprez Audrey Bruyère Olivier

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 941-951

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of ibandronate in the treatment of neoplastic bone disease

By Pecherstorfer Martin

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2341-2350

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma

By Foss Francine M

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1141-1152

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Ibandronate: In the Treatment of Osteoporosis

By Croom Katherine F. Scott Lesley J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1593-1601

Adis International

Access to resources Recommend Favorite

Review of ibandronate in the treatment of osteoporosis

By Chapurlat Roland D Delmas Pierre D

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite